Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Nov 15;12(11):1285. doi: 10.3390/vaccines12111285

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Demonstration of PCV2 antigen in inguinal lymph node of mice at 14 days post challenge (dpc). (a) Unvaccinated and infected control group showed marked (+++) immunolocalization of PCV2 antigen. (b) rNDV-R2B group showed moderate (++) to marked (+++) immunolocalization of PCV2 antigen. (c) Ingelvac CiroFLEX group showed moderate (++) immunolocalization of PCV2 antigen. (d) rNDV-R2B-PCVcap group showed mild (+) immunolocalization of PCV2 antigen. (e) rNDV-R2B-PCVcap-TMCT group showed absence of immunolocalization of PCV2 antigen. (f) Negative control showed no positive immunoreaction for PCV2 antigen. IP-DAB-MH ×20.